T cell receptor assessment in autoimmune disease requires access to the most adjacent immunologically active organ

Bergithe E. Oftedal a,b, Brita Ardesjo Lundgren a,c, David Hammd, Poh-Yi Gane, Stephen R. Holdsworthe, Christopher N. Hahna,i, Andreas W. Schreiberf,i,Hamish S. Scotta,f,g,h,i aDepartment of Genetics and Molecular Pathology, Centre for Cancer Biology, An Alliance Between SA Pathology and the University of South Australia, Adelaide, Australia, bDepartment of Clinical Science, University of Bergen, Norway, cDepartment of Medical Biochemistry and Microbiology, Uppsala University, Sweden, dAdaptive Biotechnologies, 1551 Eastlake Ave E #200, Seattle, WA, 98102, USA, eCentre for Inflammatory Diseases, Monash University Department of Medicine, Clayton, Australia, fACRF Cancer Genomics Facility, Centre for Cancer Biology, SA Pathology, Adelaide, Australia gSchool of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Australia, hSchool of Biological Sciences, University of Adelaide, Australia, iSchool of Medicine, University of Adelaide, Adelaide, Australia